The US biotech Moderna was just about the only stock on the rise yesterday amid the global COVID-19 bear market, as the Massachusetts firm announced the first patient had been tested with i
The ugly side of the coronavirus outbreak continues to dominate the news, amid reports that the Trump administration attempted to entice Germany's CureVac to move its coronavirus vaccine re
The coronavirus has begun to affect day-to-day operations at pharma companies, with Biogen dealing with an outbreak linked to a management meeting at an affected hotel, and others telling s
Gilead has said it has begun two phase 3 trials of its potential COVID-19 coronavirus antiviral remdesivir in adults affected by the disease, expanding ongoing research in the US and China.